{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:47:48Z","timestamp":1792597668538,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Shanghai Jiading district Natural Science Research Project","award":["JDKW-2025-0047"],"award-info":[{"award-number":["JDKW-2025-0047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"DOI":"10.1007\/s10856-026-07106-2","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T12:44:11Z","timestamp":1784983451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction of polyethylene glycol-cloaked mesoporous polydopamine nanomaterials co-loaded with anticancer drugs for photo\/chemotherapy of lung cancer cells and elucidation of the cell death mechanism"],"prefix":"10.1007","volume":"37","author":[{"given":"Yueming","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"7106_CR1","first-page":"1","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Prim. 2021;7:1\u201320.","journal-title":"Nat Rev Dis Prim"},{"key":"7106_CR2","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.35128","volume":"130","author":"TB Kratzer","year":"2024","unstructured":"Kratzer TB, Bandi P, Freedman ND, Smith RA, Travis WD, Jemal A, et al. Lung cancer statistics, 2023. Cancer. 2024;130:1330\u201348.","journal-title":"Cancer"},{"key":"7106_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade BC, Cruz CSDela. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41:1\u201324.","journal-title":"Clin Chest Med"},{"key":"7106_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-023-01436-2","volume":"16","author":"S-YM Liu","year":"2023","unstructured":"Liu S-YM, Zheng M-M, Pan Y, Liu S-Y, Li Y, Wu Y-L. Emerging evidence and treatment paradigm of non-small cell lung cancer. J Hematol Oncol. 2023;16:1\u201320.","journal-title":"J Hematol Oncol"},{"key":"7106_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2174\/18715206MTA1uNjQp3","volume":"21","author":"A El-Hussein","year":"2021","unstructured":"El-Hussein A, Manoto SL, Ombinda-Lemboumba S, Alrowaili ZA, Mthunzi-Kufa P. A review of chemotherapy and photodynamic therapy for lung cancer treatment. Anticancer Agents Med Chem. 2021;21:149\u201361.","journal-title":"Anticancer Agents Med Chem"},{"key":"7106_CR6","doi-asserted-by":"publisher","first-page":"2206624","DOI":"10.1002\/smll.202206624","volume":"19","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wu Y, Zuo H, Chen W, Wang K. Metal nanoparticles as novel agents for lung cancer diagnosis and therapy. Small. 2023;19:2206624.","journal-title":"Small"},{"key":"7106_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.115942","volume":"232","author":"HM Saleem","year":"2023","unstructured":"Saleem HM, Ramaiah P, Gupta J, Jalil AT, Kadhim NA, Alsaikhan F, et al. Nanotechnology-empowered lung cancer therapy: from EMT role in cancer metastasis to application of nanoengineered structures for modulating growth and metastasis. Environ Res. 2023;232:115942.","journal-title":"Environ Res"},{"key":"7106_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/17458080.2020.1746767","volume":"15","author":"T Li","year":"2020","unstructured":"Li T, Yan G, Bai Y, Wu M, Fang G, Zhang M, et al. Papain bioinspired gold nanoparticles augmented the anticancer potency of 5-FU against lung cancer. J Exp Nanosci. 2020;15:109\u201328. https:\/\/doi.org\/10.1080\/17458080.2020.1746767.","journal-title":"J Exp Nanosci"},{"key":"7106_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.actbio.2021.05.018","volume":"129","author":"W Chen","year":"2021","unstructured":"Chen W, Yu D, Sun S-Y, Li F. Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer. Acta Biomater. 2021;129:258\u201368. https:\/\/doi.org\/10.1016\/j.actbio.2021.05.018.","journal-title":"Acta Biomater"},{"key":"7106_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejca.2020.06.014","volume":"137","author":"SM Federico","year":"2020","unstructured":"Federico SM, Pappo AS, Sahr N, Sykes A, Campagne O, Stewart CF, et al. A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies. Eur J Cancer. 2020;137:204\u201313.","journal-title":"Eur J Cancer"},{"key":"7106_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41591-023-02704-x","volume":"30","author":"K Fizazi","year":"2024","unstructured":"Fizazi K, Azad AA, Matsubara N, Carles J, Fay AP, De Giorgi U, et al. First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial. Nat Med. 2024;30:257\u201364.","journal-title":"Nat Med"},{"key":"7106_CR12","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1200\/JCO.23.02182","volume":"42","author":"BL Heiss","year":"2024","unstructured":"Heiss BL, Chang E, Gao X, Truong T, Brave MH, Bloomquist E, et al. US Food and Drug Administration approval summary: talazoparib in combination with enzalutamide for treatment of patients with homologous recombination repair gene-mutated metastatic castration-resistant prostate cancer. J Clin Oncol. 2024;42:1851\u201360.","journal-title":"J Clin Oncol"},{"key":"7106_CR13","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1080\/14656566.2024.2397002","volume":"25","author":"A Narang","year":"2024","unstructured":"Narang A, Hage Chehade C, Ozay ZI, Nordblad B, Swami U, Agarwal N. Talazoparib for the treatment of prostate cancer. Expert Opin Pharmacother. 2024;25:1717\u201327.","journal-title":"Expert Opin Pharmacother"},{"key":"7106_CR14","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.ijrobp.2024.07.166","volume":"120","author":"BH Lok","year":"2024","unstructured":"Lok BH, Sacher AG, Bezjak A, Raman S, Hope AJ, Sun A, et al. Phase I Trial of Concurrent Talazoparib and Consolidative Thoracic Radiotherapy for Patients with Extensive-Stage Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2024;120:S93\u2013S94.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7106_CR15","doi-asserted-by":"publisher","first-page":"100197","DOI":"10.1016\/j.mtbio.2021.100197","volume":"13","author":"P Manivasagan","year":"2022","unstructured":"Manivasagan P, Joe A, Han H-W, Thambi T, Selvaraj M, Chidambaram K, et al. Recent advances in multifunctional nanomaterials for photothermal-enhanced Fenton-based chemodynamic tumor therapy. Mater Today Bio. 2022;13:100197.","journal-title":"Mater Today Bio"},{"key":"7106_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.actbio.2022.12.017","volume":"157","author":"X Ding","year":"2023","unstructured":"Ding X, Bai S, Liu F, Micha\u0142 N, Roman S, Peng N, et al. NIR-II-triggered photothermal therapy with Au@ PDA\/PEG-PI for targeted downregulation of PSMA in prostate cancer. Acta Biomater. 2023;157:487\u201399.","journal-title":"Acta Biomater"},{"key":"7106_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176982","volume":"983","author":"S Pinho","year":"2024","unstructured":"Pinho S, Coelho JMP, Gaspar MM, Reis CP. Advances in localized prostate cancer: a special focus on photothermal therapy. Eur J Pharmacol. 2024;983:176982.","journal-title":"Eur J Pharmacol"},{"key":"7106_CR18","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.2147\/IJN.S289310","volume":"16","author":"J Shao","year":"2021","unstructured":"Shao J, Liang R, Ding D, Zheng X, Zhu X, Hu S, et al. A smart multifunctional nanoparticle for enhanced near-infrared image-guided photothermal therapy against gastric cancer. Int J Nanomed. 2021;16:2897\u2013915.","journal-title":"Int J Nanomed"},{"key":"7106_CR19","doi-asserted-by":"publisher","first-page":"139504","DOI":"10.1016\/j.cej.2022.139504","volume":"452","author":"G Liu","year":"2023","unstructured":"Liu G, Wang Z, Sun W, Lin X, Wang R, Li C, et al. Robust emission in near-infrared II of lanthanide nanoprobes conjugated with Au (LNPs-Au) for temperature sensing and controlled photothermal therapy. Chem Eng J. 2023;452:139504.","journal-title":"Chem Eng J"},{"key":"7106_CR20","doi-asserted-by":"publisher","first-page":"116508","DOI":"10.1016\/j.ejmech.2024.116508","volume":"272","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chang L, Gao H, Yu C, Gao Y, Peng Q. Nanomaterials-based advanced systems for photothermal\/photodynamic therapy of oral cancer. Eur J Med Chem. 2024;272:116508\u2013116529.","journal-title":"Eur J Med Chem"},{"key":"7106_CR21","doi-asserted-by":"crossref","unstructured":"Huang S, Ye Y, Jiang C, Wang R, Hu W, Raza S, et al. Current and promising applications of MOFs loaded with PTAs on photothermal therapy. React Funct Polym. 2023;105743\u2013105761.","DOI":"10.1016\/j.reactfunctpolym.2023.105743"},{"key":"7106_CR22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1021\/acsnano.1c08485","volume":"16","author":"J Chen","year":"2022","unstructured":"Chen J, Gong M, Fan Y, Feng J, Han L, Xin HL, et al. Collective plasmon coupling in gold nanoparticle clusters for highly efficient photothermal therapy. ACS Nano. 2022;16:910\u201320.","journal-title":"ACS Nano"},{"key":"7106_CR23","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1021\/acs.bioconjchem.0c00172","volume":"31","author":"X Jiang","year":"2020","unstructured":"Jiang X, Du B, Huang Y, Yu M, Zheng J. Cancer photothermal therapy with ICG-conjugated gold nanoclusters. Bioconjug Chem. 2020;31:1522\u20138.","journal-title":"Bioconjug Chem"},{"key":"7106_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.apsb.2018.09.001","volume":"9","author":"R Liu","year":"2019","unstructured":"Liu R, Hu C, Yang Y, Zhang J, Gao H. Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B. 2019;9:410\u201320. https:\/\/doi.org\/10.1016\/j.apsb.2018.09.001.","journal-title":"Acta Pharm Sin B"},{"key":"7106_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijpharm.2013.12.045","volume":"463","author":"Q Zheng","year":"2014","unstructured":"Zheng Q, Lin T, Wu H, Guo L, Ye P, Hao Y, et al. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release. Int J Pharm. 2014;463:22\u201326.","journal-title":"Int J Pharm"},{"key":"7106_CR26","doi-asserted-by":"publisher","first-page":"8383","DOI":"10.2147\/IJN.S272495","volume":"15","author":"Z Ding","year":"2020","unstructured":"Ding Z, Wang D, Shi W, Yang X, Duan S, Mo F, et al. In vivo targeting of liver cancer with tissue-and nuclei-specific mesoporous silica nanoparticle-based nanocarriers in mice. Int J Nanomed. 2020;15:8383.","journal-title":"Int J Nanomed"},{"key":"7106_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.micromeso.2023.112840","volume":"363","author":"V Candela-Noguera","year":"2024","unstructured":"Candela-Noguera V, Alfonso M, Amor\u00f3s P, Aznar E, Marcos MD, Mart\u00ednez-M\u00e1\u00f1ez R. In-depth study of factors affecting the formation of MCM-41-type mesoporous silica nanoparticles. Microporous Mesoporous Mater. 2024;363:112840. https:\/\/doi.org\/10.1016\/j.micromeso.2023.112840.","journal-title":"Microporous Mesoporous Mater"},{"key":"7106_CR28","doi-asserted-by":"publisher","first-page":"101842","DOI":"10.1016\/j.mtcomm.2020.101842","volume":"26","author":"R Han","year":"2021","unstructured":"Han R, Wu S, Yan Y, Chen W, Tang K. Construction of ferrocene modified and indocyanine green loaded multifunctional mesoporous silica nanoparticle for simultaneous chemodynamic\/photothermal\/photodynamic therapy. Mater Today Commun. 2021;26:101842.","journal-title":"Mater Today Commun"},{"key":"7106_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejpb.2021.04.020","volume":"165","author":"MU Amin","year":"2021","unstructured":"Amin MU, Ali S, Ali MY, Tariq I, Nasrullah U, Pinnapreddy SR, et al. Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy. Eur J Pharm Biopharm. 2021;165:31\u201340.","journal-title":"Eur J Pharm Biopharm"},{"key":"7106_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/10667857.2020.1758474","volume":"36","author":"W Bao","year":"2021","unstructured":"Bao W, Ma H, Wang N, He Z. pH-responsive mesoporous silica drug delivery system for targeted cancer chemotherapy. Mater Technol. 2021;36:308\u201316. https:\/\/doi.org\/10.1080\/10667857.2020.1758474.","journal-title":"Mater Technol"},{"key":"7106_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.micromeso.2019.06.002","volume":"291","author":"NS Elbialy","year":"2020","unstructured":"Elbialy NS, Aboushoushah SF, Sofi BF, Noorwali A. Multifunctional curcumin-loaded mesoporous silica nanoparticles for cancer chemoprevention and therapy. Microporous Mesoporous Mater. 2020;291:109540. https:\/\/doi.org\/10.1016\/j.micromeso.2019.06.002.","journal-title":"Microporous Mesoporous Mater"},{"key":"7106_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jconrel.2021.09.005","volume":"338","author":"Z Li","year":"2021","unstructured":"Li Z, Yang Y, Wei H, Shan X, Wang X, Ou M, et al. Charge-reversal biodegradable MSNs for tumor synergetic chemo\/photothermal and visualized therapy. J Control Release. 2021;338:719\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.005.","journal-title":"J Control Release"},{"key":"7106_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112107","volume":"208","author":"Z Jin","year":"2021","unstructured":"Jin Z, Dun Y, Xie L, Jiang W, Sun X, Hu P, et al. Preparation of doxorubicin-loaded porous iron Oxide@ polydopamine nanocomposites for MR imaging and synergistic photothermal\u2013chemotherapy of cancer. Colloids Surf B Biointerfaces. 2021;208:112107. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112107.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"7106_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1208\/s12249-020-01710-3","volume":"21","author":"SS Esnaashari","year":"2020","unstructured":"Esnaashari SS, Muhammadnejad S, Amanpour S, Amani A. A Combinational Approach Towards Treatment of Breast Cancer: an Analysis of Noscapine-Loaded Polymeric Nanoparticles and Doxorubicin. AAPS PharmSciTech. 2020;21:166 https:\/\/doi.org\/10.1208\/s12249-020-01710-3.","journal-title":"AAPS PharmSciTech"},{"key":"7106_CR35","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.bioactmat.2020.10.020","volume":"6","author":"G Shu","year":"2021","unstructured":"Shu G, Chen M, Song J, Xu X, Lu C, Du Y, et al. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+ as a novel theranostic agent for T1\/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer. Bioact Mater. 2021;6:1423\u201335. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.10.020.","journal-title":"Bioact Mater"},{"key":"7106_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/10667857.2020.1734729","volume":"36","author":"VV Pande","year":"2021","unstructured":"Pande VV, Khedkar PV, Giri MA, Pote AK, Polshettiwar SA. Fabrication and Characterisation of gemcitabine hydrochloride loaded magnetically responsive mesoporous silica nanocomposites as smart hybrid theranostic platform for treatment of pancreatic cancer. Mater Technol. 2021;36:145\u201352. https:\/\/doi.org\/10.1080\/10667857.2020.1734729.","journal-title":"Mater Technol"},{"key":"7106_CR37","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/nano11092222","volume":"11","author":"M Gisbert-Garzar\u00e1n","year":"2021","unstructured":"Gisbert-Garzar\u00e1n M, Vallet-Reg\u00ed M. Redox-responsive mesoporous silica nanoparticles for cancer treatment: Recent updates. Nanomaterials. 2021;11:2222.","journal-title":"Nanomaterials"},{"key":"7106_CR38","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1039\/C2NR30938F","volume":"4","author":"X-F Qiao","year":"2012","unstructured":"Qiao X-F, Zhou J-C, Xiao J-W, Wang Y-F, Sun L-D, Yan C-H. Triple-functional core\u2013shell structured upconversion luminescent nanoparticles covalently grafted with photosensitizer for luminescent, magnetic resonance imaging and photodynamic therapy in vitro. Nanoscale. 2012;4:4611\u201323. https:\/\/doi.org\/10.1039\/C2NR30938F.","journal-title":"Nanoscale"},{"key":"7106_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2020.124470","volume":"590","author":"Y Li","year":"2020","unstructured":"Li Y, Wang S, Song FX, Zhang L, Yang W, Wang HX, et al. A pH-sensitive drug delivery system based on folic acid-targeted HBP-modified mesoporous silica nanoparticles for cancer therapy. Colloids Surf A Physicochem Eng Asp. 2020;590:124470. https:\/\/doi.org\/10.1016\/j.colsurfa.2020.124470.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"7106_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15087","volume":"9","author":"Z Nie","year":"2023","unstructured":"Nie Z, Wang D, Wang S, Wang L. Facile construction of irinotecan loaded mesoporous nano-formulation with surface-initiated polymerization to improve stimuli-responsive drug delivery for breast cancer therapy. Heliyon. 2023;9:e15087. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15087.","journal-title":"Heliyon"},{"key":"7106_CR41","doi-asserted-by":"publisher","first-page":"2206762","DOI":"10.1002\/smll.202206762","volume":"19","author":"B Yin","year":"2023","unstructured":"Yin B, Ho WKH, Xia X, Chan CKW, Zhang Q, Ng YM, et al. A multilayered mesoporous gold nanoarchitecture for ultraeffective near-infrared light-controlled chemo\/photothermal therapy for cancer guided by SERS imaging. Small. 2023;19:2206762.","journal-title":"Small"},{"key":"7106_CR42","doi-asserted-by":"publisher","first-page":"9518","DOI":"10.1021\/acsanm.4c00992","volume":"7","author":"T Liao","year":"2024","unstructured":"Liao T, Liu C, Wu X, Liu J, Yu W, Xu Z, et al. Degradable Mesoporous Silica Nanoparticle\/Peptide-Based \u201cTrojan Horse\u201d-like Drug Delivery System for Deep Intratumoral Penetration and Cancer Therapy. ACS Appl Nano Mater. 2024;7:9518\u201331.","journal-title":"ACS Appl Nano Mater"},{"key":"7106_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11051-023-05712-7","volume":"25","author":"S Shahbazi","year":"2023","unstructured":"Shahbazi S, Reiisi S, Heidari R, Raeisi M. Eugenol-loaded mesoporous silica nanoparticles enhance the sensitivity of cisplatin against AGS human gastric adenocarcinoma cell line. J Nanopart Res. 2023;25:57.","journal-title":"J Nanopart Res"},{"key":"7106_CR44","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1109\/TNB.2023.3242912","volume":"22","author":"ZR Harandi","year":"2023","unstructured":"Harandi ZR, Heidari R, Reiisi S. Co-delivery of silymarin and metformin dual-loaded in mesoporous silica nanoparticles synergistically sensitizes breast cancer cell line to mitoxantrone chemotherapy. IEEE Trans Nanobiosci. 2023;22:872\u201380.","journal-title":"IEEE Trans Nanobiosci"},{"key":"7106_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/acsabm.9b00772","volume":"3","author":"M Sedighi","year":"2020","unstructured":"Sedighi M, Rahimi F, Shahbazi M-A, Rezayan AH, Kettiger H, Einfalt T, et al. Controlled Tyrosine Kinase Inhibitor Delivery to Liver Cancer Cells by Gate-Capped Mesoporous Silica Nanoparticles. ACS Appl Bio Mater. 2020;3:239\u201351. https:\/\/doi.org\/10.1021\/acsabm.9b00772.","journal-title":"ACS Appl Bio Mater"},{"key":"7106_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2020.124494","volume":"389","author":"W Zeng","year":"2020","unstructured":"Zeng W, Zhang H, Deng Y, Jiang A, Bao X, Guo M, et al. Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy. Chem Eng J. 2020;389:124494. https:\/\/doi.org\/10.1016\/j.cej.2020.124494.","journal-title":"Chem Eng J"},{"key":"7106_CR47","doi-asserted-by":"publisher","first-page":"135227","DOI":"10.1016\/j.colsurfa.2024.135227","volume":"703","author":"H Namazi","year":"2024","unstructured":"Namazi H, Moghadam MR, Karimi S. A biocompatible drug controlled release system based on \u03b2-cyclodextrin crosslinked magnetic lactose\/ZIF-8 metal-organic frameworks for cancer treatment, Colloids Surfaces A Physicochem. Eng Asp. 2024;703:135227.","journal-title":"Eng Asp"},{"key":"7106_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.procbio.2020.09.021","volume":"100","author":"Y Hu","year":"2021","unstructured":"Hu Y, Yu D, Zhang X. 9-amino acid cyclic peptide-decorated sorafenib polymeric nanoparticles for the efficient in vitro nursing care analysis of hepatocellular carcinoma. Process Biochem. 2021;100:140\u20138. https:\/\/doi.org\/10.1016\/j.procbio.2020.09.021.","journal-title":"Process Biochem"},{"key":"7106_CR49","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s13204-021-02312-6","volume":"12","author":"J Yan","year":"2022","unstructured":"Yan J, Xie S, Xia Q, Li X, Chen S, Shen J. Engineering of combination drug delivery of pH\/reduction response potential nanocarrier for the treatment of liver cancer. Appl Nanosci. 2022;12:1545\u201356. https:\/\/doi.org\/10.1007\/s13204-021-02312-6.","journal-title":"Appl Nanosci"},{"key":"7106_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.6536","volume":"36","author":"K Giriraj","year":"2022","unstructured":"Giriraj K, Mohamed Kasim MS, Balasubramaniam K, Thangavel SK, Venkatesan J, Suresh S, et al. Various coordination modes of new coumarin Schiff bases toward Cobalt (III) ion: Synthesis, spectral characterization, in vitro cytotoxic activity, and investigation of apoptosis. Appl Organomet Chem. 2022;36:e6536. https:\/\/doi.org\/10.1002\/aoc.6536.","journal-title":"Appl Organomet Chem"},{"key":"7106_CR51","doi-asserted-by":"publisher","unstructured":"Sun W, Li S, Fabrication of Co-delivery of Bortezomib and Vincristine Loaded Chitosan Cross-linked Polymeric Nanoparticles: Evaluation of Anticancer Activity and Apoptosis Induction in Lung Cancer Cells, J Polym Environ. 2024. https:\/\/doi.org\/10.1007\/s10924-024-03451-x.","DOI":"10.1007\/s10924-024-03451-x"},{"key":"7106_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10528-020-09996-5","volume":"59","author":"D Albayrak","year":"2021","unstructured":"Albayrak D, Do\u011fanlar O, Erdo\u011fan S, Merakl\u0131 M, Do\u011fan A, Turker P, et al. Naringin Combined with NF-\u03baB Inhibition and Endoplasmic Reticulum Stress Induces Apoptotic Cell Death via Oxidative Stress and the PERK\/eIF2\u03b1\/ATF4\/CHOP Axis in HT29 Colon Cancer Cells. Biochem Genet. 2021;59:159\u201384. https:\/\/doi.org\/10.1007\/s10528-020-09996-5.","journal-title":"Biochem Genet"},{"key":"7106_CR53","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1039\/D0DT03873C","volume":"50","author":"A Paul","year":"2021","unstructured":"Paul A, Singh P, Kuznetsov ML, Karmakar A, Guedes da Silva MFC, Koch B, et al. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(ii) complexes towards estrogen dependent breast cancer cells. Dalt Trans. 2021;50:3701\u201316. https:\/\/doi.org\/10.1039\/D0DT03873C.","journal-title":"Dalt Trans"},{"key":"7106_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02678-5","volume":"42","author":"R Mahata","year":"2025","unstructured":"Mahata R, Manna S, Modak M, Choudhury SM. A review on the advancement of polydopamine (PDA)-based nanomaterials for cancer treatment. Med Oncol. 2025;42:165.","journal-title":"Med Oncol"},{"key":"7106_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/pharmaceutics18020195","volume":"18","author":"L Liu","year":"2026","unstructured":"Liu L, Hu Y, Zhang X, Huang G, Liang X, Wang S, et al. Construction of Multifunctional Fe3O4@ MSN@ PDA-HA-FA Nanocarriers and Research on Synergistic Tumor Therapy. Pharmaceutics. 2026;18:195.","journal-title":"Pharmaceutics"},{"key":"7106_CR56","doi-asserted-by":"publisher","first-page":"1531144","DOI":"10.3389\/frcdi.2025.1531144","volume":"3","author":"S Ostrowska","year":"2025","unstructured":"Ostrowska S, Szukowska M, Kim S, Kim Y, Wawrzyniak D, Mr\u00f3wczy\u0144ski R. Doxorubicin and sorafenib release from mesoporous silica nanoparticles coated with polydopamine\u2013influence of mechanical and chemical stimuli on the process. Front Coat, Dye Interface Eng. 2025;3:1531144.","journal-title":"Front Coat, Dye Interface Eng"},{"key":"7106_CR57","doi-asserted-by":"publisher","first-page":"e0201294","DOI":"10.1371\/journal.pone.0201294","volume":"13","author":"CTJ Ferguson","year":"2018","unstructured":"Ferguson CTJ, Al-Khalaf AA, Isaac RE, Cayre OJ. pH-responsive polymer microcapsules for targeted delivery of biomaterials to the midgut of Drosophila suzukii. PLoS ONE. 2018;13:e0201294.","journal-title":"PLoS ONE"},{"key":"7106_CR58","doi-asserted-by":"publisher","first-page":"102952","DOI":"10.1016\/j.apmt.2025.102952","volume":"47","author":"W Pan","year":"2025","unstructured":"Pan W, Gao F, Xu M, Rafiq M, Cong H, Yu B. Antimicrobial peptide clears bacteria from tumors to enhance gemcitabine therapy for pancreatic cancer. Appl Mater Today. 2025;47:102952.","journal-title":"Appl Mater Today"},{"key":"7106_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02681-w","volume":"42","author":"J Wang","year":"2025","unstructured":"Wang J, Deng X, Li M, Liu X, Liu Q. Mesoporous polydopamine nanoparticles coated with metal-polyphenol networks for demethylation therapy of lung cancer. Med Oncol. 2025;42:147.","journal-title":"Med Oncol"},{"key":"7106_CR60","doi-asserted-by":"publisher","first-page":"139196","DOI":"10.1016\/j.ijbiomac.2024.139196","volume":"292","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Shi W, Wu Y, Kong L, Gao J, Kong Y. A stimuli-responsive drug delivery system based on konjac glucomannan, carboxymethyl chitosan and mesoporous polydopamine nanoparticles. Int J Biol Macromol. 2025;292:139196.","journal-title":"Int J Biol Macromol"},{"key":"7106_CR61","doi-asserted-by":"publisher","first-page":"117539","DOI":"10.1016\/j.biopha.2024.117539","volume":"180","author":"D Meng","year":"2024","unstructured":"Meng D, Yang S, Ju L, Wang J, Yang Y, Zhang L, et al. Cell membrane camouflaged Cu-doped mesoporous polydopamine for combined CT\/PTT\/CDT synergistic treatment of breast cancer. Biomed Pharmacother. 2024;180:117539.","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-026-07106-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-026-07106-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-026-07106-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:02:28Z","timestamp":1792594948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-026-07106-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7106"],"URL":"https:\/\/doi.org\/10.1007\/s10856-026-07106-2","relation":{},"ISSN":["1573-4838"],"issn-type":[{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"128"}}